PMDA drug package insert
ダントリウム静注用20mg
PMDA Prescription drug · 株式会社オーファンパシフィック · package insert Nov 13, 2023
Key facts
| Brand names | ダントリウム静注用20mg |
|---|---|
| Nonproprietary names | ダントロレンナトリウム水和物 |
| Companies | 製造販売元／株式会社オーファンパシフィック |
| Product type | Prescription drug |
| Therapeutic category | 悪性高熱症治療剤・悪性症候群治療剤 |
| Therapeutic category codes | 871229 |
| YJ codes | 1229402D1039 |
| Approval numbers | 21800AMX10138000 |
| Package insert edition | 第1版 |
| Package insert date | Nov 13, 2023 |
| PMDA document key | 181251_1229402D1039_2 |
| PMDA company code | 181251 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: